NervGen Pharma Corp. (NGEN) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$2.27

From 52W high−65.66%

Volume606127.00

Market cap$220.42M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$2.27

From 52W high

−65.66%

Volume

606127.00

Market cap

$220.42M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−19.1x

P/E (TTM)

—

RSI (14)

51.0

MomentumView details →

1D Return

−9.69%

YTD Return

−62.32%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−19.1x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

17.8x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−390.39%

ROA (TTM)

−74.79%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−69.44%

EBITDA YoY

+49.35%

MomentumView details →

1D Return

−9.69%

YTD Return

−62.32%

1Y Return

—

RSI (14)

51.0

vs 50D SMA

+11.09%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.23x

Quick Ratio

1.23x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.37

EPS Surprise

−510.76%

Beats (12Q)

1/12

Next Q EPS Est

−$0.07

Avg Surprise (4Q)

−198.51%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−67.56M

Op. CF (TTM)

−29.60M

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for NGEN.

Similar companies

Keros Therapeutics, Inc.KROS Adagene Inc.ADAG Invivyd, Inc.IVVD Anavex Life Sciences Corp.AVXL Alector, Inc.ALEC Eledon Pharmaceuticals, Inc.ELDN Find similar companies →

Latest newsMore news →

No recent news for NGEN.